Moderna and Pfizer with 5.5% interest and 50% protection In the case of bonds and certificates whose potential returns depend…
Read More »Pfizer
BioNTech’s partner Pfizer has apparently admitted that there will be bottlenecks in deliveries of the COVID-19 vaccine in the next…
Read More »BioNTech and its sales partner Pfizer will deliver an additional 100 million doses of the COVID-19 vaccine BNT162 to the…
Read More »BioNTech and Pfizer will shortly be able to announce approval for their vaccine against the pathogen causing COVID-19 in the…
Read More »
Update 12:55 p.m.: According to the AFP news agency, approval of the vaccine before Christmas in Europe is anything but…
Read More »
After the decisions at the most recent crucial meeting of the responsible Fed committee, it was actually just a mere…
Read More »Pfizer discounter with 8% chance and 21% discount The shares of the US group Pfizer (ISIN: US7170811035), one of the…
Read More »
The corona vaccine developed by BioNTech and Pfizer shows, according to the latest reports, an effectiveness of 95 percent. So…
Read More »The results of the phase III study by Pfizer and BioNTech for their corona vaccine are well received by the…
Read More »
D.he fear of weakening economic stimuli and economic damage from the rampant corona pandemic weighed on the US stock exchanges…
Read More »